SCHEMBL7259993

SCHEMBL7259993

COc1cc(C2=C3C=CC(=N3)C=C3C=CC(=N3)C=C3C=CC(=N3)C=C3C=CC2=N3)cc(OC)c1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ HPGD P15428 3/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CCNB2 O95067 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ GSK3A P49840 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ GAA P10253 2/20 0.31
▸ ERN1 O75460 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ APOBEC3G Q9HC16 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28278669 0.86 — —
SCHEMBL17391664 0.83 PTGS2 (0.38) —
SCHEMBL498534 0.83 KDM4E (0.44) KDM4EALDH1A1HPGDL3MBTL1CCNB2
SCHEMBL6804334 0.82 CYP1A1 (0.33) KDM4EALDH1A1CCNB2CDK1CCNB1
SCHEMBL27646301 0.81 KDM4E (0.30) KDM4EALDH1A1TDP1TSHR
SCHEMBL2950392 0.81 KDM4E (0.36) KDM4EALDH1A1HPGDL3MBTL1CCNB2
SCHEMBL27809129 0.80 KDM4E (0.39) KDM4EALDH1A1HPGDL3MBTL1MAPT
SCHEMBL8189724 0.79 KDM4E (0.34) KDM4EALDH1A1HPGDCDK1CCNB1
SCHEMBL2226184 0.79 CYP1A2 (0.32) ALDH1A1CYP3A4
SCHEMBL27949938 0.76 KDM4E (0.30) KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203888-A1 Chromophores WELLCOME TRUST LIMITED, THE (GB) 2003-10-30 — — US disclosed
EP-1294726-A2 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES Catalyst Biomedica Ltd (GB) 2003-03-26 — — EP disclosed
WO-2002000662-A1 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES CATALYST BIOMEDICA LIMITED (GB) 2002-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203888-A1 Chromophores HCCS, PPOX, HMBS KDM4E 4639/4885ALDH1A1 2976/4885HPGD 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback